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Abstract
Background: Obesity induced by high fat (HF) diet is associated with inflammation which contributes to development of
insulin resistance. Most prior studies have focused on adipose tissue as the source of obesity-associated inflammation.
Increasing evidence links intestinal bacteria to development of diet-induced obesity (DIO). This study tested the hypothesis
that HF western diet and gut bacteria interact to promote intestinal inflammation, which contributes to the progression of
obesity and insulin resistance.
Methodology/Principal Findings: Conventionally raised specific-pathogen free (CONV) and germ-free (GF) mice were given
HF or low fat (LF) diet for 2–16 weeks. Body weight and adiposity were measured. Intestinal inflammation was assessed by
evaluation of TNF-a mRNA and activation of a NF-kB
EGFP reporter gene. In CONV but not GF mice, HF diet induced increases
in body weight and adiposity. HF diet induced ileal TNF-a mRNA in CONV but not GF mice and this increase preceded
obesity and strongly and significantly correlated with diet induced weight gain, adiposity, plasma insulin and glucose. In
CONV mice HF diet also resulted in activation of NF-kB
EGFP in epithelial cells, immune cells and endothelial cells of small
intestine. Further experiments demonstrated that fecal slurries from CONV mice fed HF diet are sufficient to activate
NF-kB
EGFP in GF NF-kB
EGFP mice.
Conclusions/Significance: Bacteria and HF diet interact to promote proinflammatory changes in the small intestine, which
precede weight gain and obesity and show strong and significant associations with progression of obesity and
development of insulin resistance. To our knowledge, this is the first evidence that intestinal inflammation is an early
consequence of HF diet which may contribute to obesity and associated insulin resistance. Interventions which limit
intestinal inflammation induced by HF diet and bacteria may protect against obesity and insulin resistance.
Citation: Ding S, Chi MM, Scull BP, Rigby R, Schwerbrock NMJ, et al. (2010) High-Fat Diet: Bacteria Interactions Promote Intestinal Inflammation Which Precedes
and Correlates with Obesity and Insulin Resistance in Mouse. PLoS ONE 5(8): e12191. doi:10.1371/journal.pone.0012191
Editor: Silvana Gaetani, Sapienza University of Rome, Italy
Received April 15, 2010; Accepted July 1, 2010; Published August 16, 2010
Copyright:  2010 Ding et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by a postdoctoral fellowship award to M. Chi (T32 MH075854-05) and a pilot grant from the National Institute of
Environmental Health Sciences (P30ES10126). IDOC: http://www.cpc.unc.edu/idoc. NIEHS: http://cehs.sph.unc.edu/index.html. The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: shengli_ding@med.unc.edu
Introduction
It is now widely accepted that obesity is associated with low-
grade chronic inflammation and that inflammation contributes to
risk of insulin resistance and type 2 diabetes as well as other
detrimental health consequences linked to obesity [1,2,3]. Most
prior studies have focused on adipocytes as sources of inflamma-
tory mediators in obesity. Circulating and adipose derived
cytokines such as tumor necrosis factor-a (TNF-a) or interleukin-
6 (IL-6) have been shown to be elevated in obese humans [4,5,6,7]
and this can be reversed with weight loss [8]. In animal models,
multiple studies have demonstrated that diet-induced obesity is
associated with increased expression of a number of proinflam-
matory cytokines or biomarkers of inflammation in adipose tissue
[9,10]. The mechanisms underlying obesity-associated inflamma-
tion are not fully defined. A number of studies support a concept
that inflammation may derive from the accumulation of activated
macrophages within adipose tissue and, particularly, surrounding
enlarged adipocytes of obese animals or humans [10,11]. The
source of adipocyte-derived macrophages in obesity is not known
but HF diet induces expression of adhesion molecules in adipose
tissue, which are associated with leukocyte migration and
adherence [9]. The gastrointestinal (GI) tract is another potential
source of inflammation associated with diet or obesity that has not
been extensively explored. Recent studies suggest that normal non-
pathogenic enteric bacteria play a key role in diet-induced
adiposity because GF mice were reported to have less body fat
[12] and do not become obese or insulin resistant when subject to
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microbiota [14]. Gut bacteria metabolize indigestible polysaccha-
rides to generate short-chain fatty acids and monosaccharides and
promote their absorption and storage as fat [12]. In addition, gut
bacteria increase vascularization and blood flow within the
mucosa, facilitating nutrient absorption. Gut bacteria also suppress
the expression and release of fasting induced adipose factor (Fiaf)
from small intestine, resulting in increased activity of lipoprotein-
lipase (LPL) in adipocytes and enhanced storage of liver-derived
triglycerides [12,13]. Despite the fact that non-pathogenic bacteria
can promote proinflammatory changes in the intestine, the role of
gut bacteria in diet-induced intestinal inflammation and the role of
intestine inflammation in susceptibility to weight gain, obesity or
insulin resistance have not to our knowledge been explored.
The current study tested the hypothesis that interactions exist
between HF western diet and gut microbiota, which promote
intestinal inflammation. To test this hypothesis we compared
inflammation biomarkers in the intestine of conventionally raised
(CONV) or GF mice given HF or LF diet. We also predicted that
intestinal inflammation would precede or correlate with the
development of obesity and/or insulin resistance and therefore
examined how the timeframe of inflammatory changes in the
intestine related to diet induced increases in body weight or fat
mass, or insulin resistance. Levels of mRNA encoding TNF-a,a
putative mediator of insulin resistance associated with obesity [15]
and activation of an nuclear factor kappa-B (NF-kB) response
element – enhanced Green Fluorescent Protein (EGFP) reporter
transgene (NF-kB
EGFP) were used as biomarkers of inflammation.
Cellular sites of NF-kB
EGFP activation were also examined to
define the cell-types in the intestine that exhibit HF diet-mediated
inflammation. Our studies support a concept that HF diet in
association with commensal gut microbiota promotes intestinal
inflammation in multiple cell types. Onset of intestinal inflamma-
tion precedes diet-induced increases in body weight, fat mass and
insulin resistance and degree of TNF-a induction strongly
correlates with diet-induced increases in weight, adiposity, plasma
glucose, and insulin.
Methods
Ethics Statement
All studies were approved by the Institutional Animal Care and
Use Committee (IACUC) of the University of North Carolina at
Chapel Hill (Approved protocol number: 07-229).
Animals
Four week old CONV but specific pathogen free (SPF) C57BL/
6 mice were purchased from Jackson Laboratories (Jackson labs,
Bar Harbor, ME) and were subjected to dietary intervention in our
SPF animal facility. GF C57BL/6 mice were bred in the UNC-
CH gnotobiotic facility and maintained in GF conditions
throughout the dietary interventions. NF-kB
EGFP knockin mice
(C57BL/6) were described previously [16]. Briefly, this model
contains a single copy of a transgene comprising NF-kB-response
elements driving EGFP knocked into the hypoxanthine phosphor-
ibosyltransferase genomic locus. These mice are maintained as
hemizygotes and transgenics were identified by examining tail-
clips for EGFP expression. Male CONV and GF NF-kB
EGFP mice
were used for proposed studies.
Diet intervention
CONV mice, CONV NF-kB
EGFP mice and GF mice were
randomly selected to receive either HF diet (45% kcal from fat,
D01060502, Research Diets, New Brunswick, NJ) or a LF diet
(10% kcal from fat, D01060501, Research Diets, New Bruns-
wick, NJ) for 2, 6, or 16 weeks (n=4–8 per group). For
experiments in GF mice, diets were subject to irradiation
(50 kGy) (Neutron Products, MD). Pilot studies established that
CONV mice given irradiated diet gained similar weight as on
non-sterile diet.
Body weight and body composition
Body weights were measured at two week intervals. Percentage
body fat was assessed by performing Dual Energy x-ray
Absorptiometry (DEXA) scan (PIXImus Mouse Densitometer,
GE, Piscataway, NJ) at 2, 6, or 16 weeks after beginning the HF or
LF diets. DEXA scans were obtained under isoflurane anesthesia
to assess fat mass, percent fat and lean body mass.
Sample Collection
Animals were euthanized with an overdose of sodium
pentobarbital administered intraperitoneally. Cardiac puncture
was used to obtain blood, which was placed on ice and centrifuged
to collect plasma. Ileum and colon were dissected and carefully
stripped of all adherent mesentery or fat. Corresponding segments
of tissue from each animal were fixed in 10% formalin or 4%
paraformaldehyde (PFA) for histology, or frozen for RNA
extraction.
Fasting plasma glucose and insulin measurement
Fasting plasma glucose was measured by a standard biochem-
ical method (#439-90901, Wako Diagnostics, Richmond, VA)
and fasting insulin by ELISA (#EZRMI-13K, rat/mouse insulin
ELISA kit, Millipore, Billerica, MA). Homeostatic model assess-
ment (HOMA) values were calculated as an estimate of insulin
sensitivity, using the formula fasting plasma glucose (mmol/L)
6insulin (mU/ml)/22.5. Higher values of HOMA indicate reduced
insulin sensitivity.
RNA extraction and Real-time PCR
Total RNA was isolated from ileum and colon using the TRIzol
method (Invitrogen, Carlsbad, CA). cDNA was generated using
AMV Reverse Transcriptase and Oligo(dT)15 primer in the presence
of RNasin Ribonuclease Inhibitor. All reverse transcription reagents
were obtained from Promega (Madison, WI). Real-time qPCR was
performed on the Light Cycle (Rotor-Gene 3000, Corbett Life
Science, San Francisco, CA). Primers and fluorescent reporter probes
were obtained from Operon (Huntsville, AL). The sequences were as
follows: TNF-a F: 59-CTGTCTACTGAACTTCGGGGTGAT-39,
R: 59-CATCAGTTCTATGGCCCAGACC-39 and FAM-labeled
probe: 59-FAM-ATGAGAAGTTCCCAAATGGCCTCCCTC-T-
AMRA-39). The results were normalized to housekeeping gene
HMBS F: 59-TGTGTTGCACGATCCTGAAAC-39,R :5 9-
CTCCTTCCAGGTGCCTCAGAA-39 and 59-FAM-TTCGCT-
GCATTGCTGAAAGGG-TAMRA-39 probe. Cycle threshold (Ct)
valuesforTNF-a and HMBS were converted to quantification values
based on the standard curves. All individual values are expressed as a
fold change compared to LF diet at the 2 week time point.
Enhanced GFP (EGFP) imaging
NF-kB
EGFP mice given HF or LF diet were anesthetized and
euthanized. The intestine was dissected and flushed with ice cold
16PBS and immediately imaged using a charge-coupled device
camera in a light-tight imaging box with a dual-filtered light
source and emission filters specific for EGFP (LT-99D2 Illuma-
tools; Lightools Research, Encinitas, CA). Intestines from HF/LF
diet fed animals were also photographed using a Leica 16FA stereo
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capture images within each experiment.
Cellular sites of NF-kB EGFP expression
GFP was visualized directly under confocal microscope on
frozen section mounted in gel-mount. Immunofluorescence was
performed on frozen sections cut from ileum and colon fixed in
4% PFA, cryoprotected in graded sucrose and embedded in
O.C.T. (Tissue-Tek, Torrance, CA). Before the primary antibody
incubation, frozen sections were pretreated with 0.05M Tris
Triton (TT) epitope retrieval solution at room temperature (RT)
for 30 minutes and blocked in 5% normal goat serum (NGS)
diluted in TT buffer for 1 hr. The primary antibodies used are
listed in Table 1. Primary antibodies were diluted in 5% NGS/TT
buffer. The sections were incubated with primary antibodies
overnight at 4uC in a humidity chamber. After washing 3 times in
0.05M Tris buffer, the sections were incubated with secondary
antibodies (see Table 2) for 1 hr at RT. Nucleic acid staining was
carried out by labeling with Bisbenzamide for 10 minutes.
Following three washes with 0.05M Tris, coverslips were mounted
in gel-mount (Electron Microscopy Sciences, Hatfield, PA).
Pictures were taken by Leica SP2 Upright Laser Scanning
Confocal microscope (Leica) and analyzed with Leica SP2 Upright
Laser Scanning Confocal Imaging Software (Leica).
Conventionalization of GF NF-kB
EGFP with fecal slurries
from mice given HF or LF diet
Fresh feces were obtained from CONV mice fed HF or LF diet
for .16 weeks. Fecal slurries were made by suspending 1.2 g of
HF/LF feces into 4 ml sterile 16PBS (phosphate buffered saline).
Whiskers and rectum of each mouse were swabbed with a cotton
swab doused in fecal slurry. Colonized GF mice were then fed with
sterilized regular chow diet and sterile water for 2 weeks before
euthanasia.
Statistical analysis
Data are expressed as mean 6 standard error. Data in CONV or
GF mice were compared for an effect of diet by One-Way ANOVA
and post-hoc tests used for pair-wise comparisons (Tukey’s test). Linear
regression using Pearson’s correlation coefficients was used to test for
correlations between ileal TNF-a and body weight, fat mass, % fat,
plasma glucose and insulin levels. All statistical analyses were
performed using STATISTICA software version 9 (Statsoft inc. Tulsa,
OK). A P value of less than 0.05 was considered statistically significant.
Results
HF diet increased body weight and percentage of body
fat in CONV mice
CONV mice on HF and LF diets had similar body weights at the
outset of the experiment (Figure 1). By week 12 and for the
remainder of the experiment CONV mice fed HF diet showed
statistically significant increases in body weight (P,0.01) relative to
LF diet controls (Figure 1A). In contrast, GF mice fed HF vs LF diet
did not differ in body weight at any time point (P.0.05 at all time
points) and GF micefed either HF or LF diet exhibited body weights
over the 16 week period that were indistinguishable from CONV
mice on LF diet (Figure 1A and B). CONV mice given HF and LF
diet had similar percentage of body fat and fat mass at 2 weeks after
onset of dietary intervention. By week 6, CONV mice on HF diet
had significantly increased percent body fat and fat mass compared
with the animals on LF diet and this increase was more dramatic by
16 weeks (P,0.001) (Figure 1C and E). Notably, GF mice fed HF
diet showed no significant increase in percent body fat compared
with GF mice fed LF diet at any time point (Figure 1D). GF animals
Table 1. Primary antibodies used in immunofluorescence.
Primary antibodies Company Cat. number Dilution
GFP Aves labs, Tigard, OR F-1005 1:500
F4/80 Abcam, Cambridge, MA ab6640 1:50
CD45R Abcam, Cambridge, MA ab64100 1:200
CD3 Dako, Carpinteria, CA A0452 1:100
Neutrophil Abcam, Cambridge, MA ab2557 1:50
CD11c Abcam, Cambridge, MA ab3385 1:100
CD45 Biolegend, San Diego, CA 30-F11 1:50
Substance P Millipore, Billerica, MA MAB356 1:100
a-smooth muscle actin (SMA) Dako, Carpinteria, CA M0851 1:200
PECAM-1 Santa Cruz Biotechnology, Santa Cruz, CA sc-1506 1:100
doi:10.1371/journal.pone.0012191.t001
Table 2. Secondary antibodies used in immunofluorescence.
Secondary antibodies Company Cat. number Dilution
Alexa Fluor 488 Goat anti chicken IgG Invitrogen, San Diego, CA A11039 1:250
Alexa Fluor 568 Goat anti rabbit IgG Invitrogen, San Diego, CA A11036 1:250
Alexa Fluor 568 Goat anti rat IgG Invitrogen, San Diego, CA, A11077 1:250
Dylight Goat anti Hamster IgG Jackson Immuno 127-505-099 1:250
doi:10.1371/journal.pone.0012191.t002
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diet, and the increase was much less than observed on CONV mice
(Figure 1F). Together these data confirm prior findings [12,13] that
GF mice are resistant to diet induced weight gain or obesity.
HF diet induced ileal TNF-a mRNA expression in CONV
mice but not GF mice
Real-time quantitative PCR for TNF-a was used as a sensitive
biomarker of proinflammatory changes in the intestine. Ileum and
colon were examined because we reasoned that HF diet was most
likely to alter nutrient exposure in these segments and these
regions have the highest densities of enteric bacteria in CONV
mice. As shown in Figure 2, ileal TNF-a mRNA levels were
significantly (P,0.01) increased in CONV mice at 6 and 16 weeks
after onset of HF diet compared to CONV mice on LF diet
(Figure 2A). In addition, after only two-weeks of HF diet, there was
a trend towards a significant increase (2.2260.72 vs 1.00)
(P=0.075) in levels of ileal TNF-a mRNA (Figure 2A). In
Figure 1. Body weight and fat mass in CONV or GF mice on HF/LF diet. Histograms show mean 6 SE. a: P,0.05 vs LF group at the same time
point; b: P,0.05 vs CONV HF at 2wk and 6wk.
doi:10.1371/journal.pone.0012191.g001
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ileal TNF-a mRNA at any time point (Figure 2B). HF diet did not
significantly affect TNF-a mRNA levels in colon of either CONV
or GF mice (Figures 2C and D). Thus ileal TNF-a mRNA,
encoding a key proinflammatory cytokine, is induced by HF diet
but only when natural enteric bacteria are present.
Ileal TNF-a mRNA correlates with body weight and
percent fat in CONV but not GF mice
Linear regression was used to test for potential association
between ileal TNF-a mRNA and body weight or adiposity. In
CONV mice, strong and significant correlations were observed
between ileal TNF-a mRNA and percent fat at all time points
whereas no significant correlations were observed in GF mice
(Table 3). Body weight in CONV mice also significantly correlated
with ileal TNF-a mRNA overall and at 6 and 16 weeks after onset
of HF/LF diet and this relationship was not observed in GF mice.
Correlations persist when we analyzed only mice on HF diet,
suggesting that the levels of ileal TNF-a are significantly correlated
with magnitude of HF-induced weight gain and obesity. (Table 4).
Ileal TNF-a mRNA and insulin resistance
Since TNF-a has been linked to obesity associated insulin
resistance, we assessed plasma glucose, insulin and HOMA in
CONV mice fed HF or LF diet and tested for correlations with
ileal TNF-a. As has been observed previously in CONV C57BL/6
mice, HF diet was associated with dramatic elevations in plasma
insulin and HOMA but only after 16 weeks of diet (Figure 3A and
3C). Other than a small and transient increase in plasma glucose
in mice fed HF diet for 2 weeks, plasma glucose did not differ
significantly in CONV mice fed HF or LF diet (Figure 3B),
indicating that the elevated insulin at 16 weeks was sufficient to
maintain normal plasma glucose. Importantly in CONV mice ileal
TNF-a showed strong and highly significant correlation with
plasma insulin and plasma glucose (R values: insulin=0.89,
P,0.05; glucose=0.93, P,0.05) at the 16-week time point
(Table 5), and this was a particularly strong correlation. Together
these data indicate that increased ileal TNF-a mRNA shows
Figure 2. TNF-a mRNA levels in intestine of CONV or GF mice on HF/LF diet. Histograms show mean 6 SE expressed as fold change vs the
mean mRNA level in mice fed LF diet for 2 weeks. a: P,0.05 vs CONV LF diet group.
doi:10.1371/journal.pone.0012191.g002
Table 3. Correlation coefficients between ileal TNF-a and
body weight, adiposity in all CONV and GF mice on HF and LF
diet at different time point.
2 weeks 6 weeks 16 weeks
CONV GF CONV GF CONV GF
Body weight 0.61 20.06 0.72
a 20.54 0.75
a 0.26
Fat mass 0.77
a 20.41 0.71
a 20.54 0.82
a 0.32
% fat 0.82
a 20.36 0.67
a 20.46 0.87
a 0.29
doi:10.1371/journal.pone.0012191.t003
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subsequent development of insulin resistance induced by HF diet.
HF diet induced intestinal NF-kB
EGFP
As an independent measure of intestinal inflammation induced
by high fat diet, we fed CONV NF-kB
EGFP mice with HF or LF
diet for 2, 6, or .16 weeks. At euthanasia, small intestine and
colon were dissected and opened for fluorescence imaging. As
shown in Figure 4, HF diet resulted in increased NF-kB
EGFP
activation, throughout the entire small intestine and colon. This
was evident at 2 weeks, suggesting that HF diet activated
proinflammatory signaling in the intestine as early as 2 weeks
after the diet intervention and this effect was maintained as long as
HF diet continued (Figure 4). It should be noted that the
informative and specific images in Figure 4 are the foci and bright
patches of NF-kB
EGFP which are also readily evident at high
power under the dissecting microscope. A diffuse signal (Figure 4)
throughout the intestine of the HF animal at 2 weeks likely reflects
background due to autofluorescence of traces of chow that are not
completely removed upon flushing the intestine. This is particular
evident in the proximal colon (indicated by the arrow) where it is
difficult to completely remove traces of chow from mucosal folds.
To confirm specific fluorescence signals, tissues were visualized at
higher power under a dissecting microscope (Figure 5) and
histologically (Figure 6). Figure 5 shows high power images viewed
under a dissecting microscope which reveals large and small foci of
inflammation in small intestine of NF-kB
EGFP mice fed HF diet for
16 weeks. Large foci represent histological analyses reveal that NF-
kB
EGFP activation in Peyers Patches or lymphoid aggregates. The
smaller foci of NF-kB
EGFP activation evident throughout the
intestine of mice fed HF reflects NF-kB
EGFP activation in epithelial
cells and multiple types of sub-epithelial cell (Figures 6, 7 and 8).
Fecal slurries from mice fed HF diet are sufficient to
activate NF-kB
EGFP in GF NF-kB
EGFP mice
We colonized GF NF-kB
EGFP mice with fecal slurries from
CONV mice fed HF or LF diet, then fed both groups standard
chow and examined NF-kB
EGFP activation two weeks later.
Imaging showed enhanced NF-kB
EGFP activation in mice
colonized with HF fecal slurry compared with those colonized
by LF fecal slurry (Figure 9).
Cellular sites of NF-kB
EGFP activation in CONV mice fed
HF diet
To identify the cells with activated NF-kB
EGFP, we localized
NF-kB
EGFP fluorescence in sections of ileum. NF-kB
EGFP was
observed in multiple cell types including intestinal epithelial cells,
sub-epithelial cells, some, but not all cells within sub-epithelial
immune aggregates and cells within blood vessels (Figure 6). We
note that the patterns of NF-kB
EGFP induction are striking with
focal patches of epithelial cells showing NF-kB
EGFP induction.
This may reflect localized effects of diet:bacteria interactions to
activate NF-kB. The GFP is present throughout the epithelial cells
including the brush border. This pattern is similar to that reported
in LPS treated NF-kB
EGFP mice [16]. Since GFP accumulates
within the cell due to activation of upstream NF-kB regulatory
Table 4. Correlation coefficients between ileal TNF-a mRNA
and body weight, adiposity in all CONV and GF mice on both
diets and in CONV mice on HF diet only.
All weeks HF diet only
CONV GF CONV
Body weight 0.51
a 20.18 0.55
a
Fat mass 0.60
a 20.29 0.59
a
% fat 0.63
a 20.31 0.61
a
a: P,0.05.
doi:10.1371/journal.pone.0012191.t004
Figure 3. Metabolic measurements in CONV mice fed HF or LF
diet. Data are expressed as mean 6 SE; Note that food was withdrawn
from mice 4 hours before plasma collection for insulin and glucose
assays. a: P,0.05 vs LF group.
doi:10.1371/journal.pone.0012191.g003
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reflects diffusion of GFP throughout the intestinal epithelial cell.
To better define the cellular sites of NF-kB
EGFP induction by HF
diet in other cell types, co-immunofluorescence (IF) was performed
for a number of cellular antigens and EGFP. IF for GFP
confirmed expression in intestinal epithelial cells, subsets of CD3+
and CD45+ immune cells, rare enteroendocrine cells expressing
substance P and PECAM positive endothelial cells (Figure 7). Thus
HF diet induces inflammatory changes in multiple cell types.
Interestingly, as shown in Figure 8, we could find no co-expression
of GFP and antigenic markers of mucosal macrophages (F4/80),
neutrophils, B cells (CD45R) (Figure 8), dendritic cells (CD11c)
Figure 4. White light and EGFP imaging of intestine in CONV NF-kB
EGFP mice on HF/LF diet. White arrow: autofluorescence which is
common in proximal colon. A: 2 weeks on HF/LF diet. B: 6 weeks on HF/LF diet. C: .16 weeks on HF/LF diet. Abbreviations: Duo: duodenum;
Jej:Jejunum; Ile: ileum; Col:colon.
doi:10.1371/journal.pone.0012191.g004
Table 5. Correlation coefficients between ileal TNF-a mRNA
and plasma glucose and insulin levels in CONV mice fed HF
and LF diets.
All weeks 2 weeks 6 weeks 16 weeks
Glucose 0.25 0.07 0.32 0.93
a
Insulin 0.53
a 21.29 0.40 0.89
a
a: P,0.05.
doi:10.1371/journal.pone.0012191.t005
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EGFP mice fed HF/LF diet for 16 weeks. A, B and C show representative images from 2 different
mice given HF diet to illustrate large foci (Peyer’s patches/lymphoid aggregates) and smaller foci (throughout the intestine) of NF-kB
EGFP expression
(white arrows); D shows minimal NF-kB
EGFP activation in mice fed LF diet. A: large foci in jejunum (.7.116magnification). B: large and small foci in
ileum (7.116magnification). C: large and small foci in ileum (7.116magnification). D: large and small foci in distal ileum (.7.116magnification).
doi:10.1371/journal.pone.0012191.g005
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cells (did not shown).
Discussion
Inflammation associated with obesity is considered central to the
development of complications such as insulin resistance. Although
the intestine is the first organ exposed to ingested nutrient has an
intrinsic resident immune system, surprisingly little attention has
focused on the potential effect of diet on intestinal inflammation or
its association with weight gain or complications such as insulin
resistance. Normal commensal enteric bacteria are known to
trigger a low grade inflammatory response in the intestine and are
also increasingly linked to DIO [12,17,18]. However, the potential
role of commensal microbiota in diet-induced intestinal inflam-
mation has not been widely studied. The current study tested the
hypothesis that HF diet interacts with intestinal bacteria to induce
intestinal inflammation. In support of this hypothesis, our study
revealed that HF diet induces two inflammatory biomarkers in the
intestine, TNF-a mRNA and NF-kB activation. Furthermore, the
presence of enteric bacteria is required for HF diet to induce TNF-
a and NF-kB since GF mice given HF diet did not exhibit up-
regulation of these markers. Strong correlation between ileal TNF-
a mRNA, weight gain, adiposity, plasma insulin and glucose in
CONV mice fed HF diet, and the fact that induction of intestinal
inflammation biomarkers preceded diet-induced weight gain and
adiposity suggests that the role of intestinal TNF-a and intestinal
inflammation in DIO and complications should be further
explored.
Bacteria and HF diet interaction leads to intestinal
inflammation and obesity
Our finding that GF mice are resistant to DIO, weight gain and
adiposity is consistent with recent findings of Backhed [12,13].
However, in contrast to Backhed, we did not observe increased
body weight, % fat or fat mass in age-matched CONV mice versus
GF mice at baseline. In GF mice, HF diet did lead to a small
increase in fat mass by 16 weeks, but this was much less dramatic
than in CONV mice, which also showed earlier HF-diet induced
increases in fat mass than GF mice. These data underscore that an
interaction between bacteria and HF diet produces earlier and
larger changes in body weight and adiposity than either of the
factors individually.
Our finding that CONV but not GF mice showed induction of
ileal TNF-a after HF diet demonstrates that an interaction
between enteric microbiota and HF diet must occur to elicit
Figure 6. Representative regions of NF-kB
EGFP activation-epithelial cells over lymphoid aggregate, subepithelial cells, cells within
blood vessel. A: NF-kB
EGFP activation in cells within blood vessel (106). B: NF-kB
EGFP activation in epithelial cells over lymphoid aggregate (206). C:
NF-kB
EGFP activation in epithelial cells over lymphoid aggregate (106). D: NF-kB
EGFP activation in epithelial cells over lymphoid aggregate and
subepithelial cells (206).
doi:10.1371/journal.pone.0012191.g006
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alters the composition of bacteria, favoring high levels luminal
Firmicutes and Proteobacteria and lower levels of Bacteroidetes
[14,19]. Other studies have demonstrated that HF diet increases
the proportion of lipopolysaccharide (LPS) –containing gut
bacteria and increases intestinal permeability leading to elevated
circulating LPS concentrations [17]. Such diet induced changes in
intestinal microbiota and intestinal permeability may contribute to
the intestinal inflammation observed in CONV mice fed HF diet.
Findings that fecal slurries from animals fed HF diet were sufficient
to enhance activation of the NF-kB
EGFP reporter in animals fed
normal chow support a concept that alterations in gut microbiota
due to HF diet are sufficient to elicit intestinal inflammation even
in animals consuming normal chow. Similarly a recent study
demonstrated that HF diet altered the composition of luminal
bacteria in mice genetically engineered to be resistant to obesity
[19]. Thus, diet-associated alterations in intestinal microbiota can
precede obesity.
HF diet-induced inflammation in CONV mice precedes
weight gain and adiposity
In CONV mice fed HF diet, increases in TNF-a mRNA and
NF-kB
EGFP activation preceded HF diet induced weight gain
and preceded or occurred coincidentally with the earliest
Figure 7. Immunostaining for antigenic markers (red) compared with NF-kB (green) and overlay showing colocalization (white
arrows).
doi:10.1371/journal.pone.0012191.g007
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mRNA, using highly sensitive real-time PCR or the NF-kB
EGFP
reporter represent a useful biomarker of early proinflammatory
e f f e c t so fH Fd i e to ni n t e s t i n e .I ti so fi n t e r e s tt h a tt h eH Fd i e t
associated increase in TNF-a occurred in ileum and not in
colon, suggesting that future evaluation of effects of HF diet
specifically on small bowel microbiota will be of interest. The
induction of these proinflammatory biomarkers prior to the
onset of significant weight gain (at 8 weeks) and measurable
increases in adiposity (6 weeks), contrast with adipose inflam-
mation, which typically occurs after onset of DIO. This supports
a concept that early proinflammatory effects of HF diet:bacteria
interactions in the intestine could serve as a trigger for
subsequent inflammation in other organs or systemic inflam-
mation.
Evaluation of cellular sites of intestinal inflammation induced
by HF diet in CONV mice based on NF-kB
EGFP reporter
activation indicate involvement of multiple cell types including
epithelial cells, intramucosal CD45 positive leukocytes, and CD3
positive T cells, and endothelial cells. Proinflammatory mole-
cules released by these cells are ideally placed to enter the
hepatic circulation and could impact on development of systemic
inflammation or insulin resistance. It is of interest that epithelial
sites of NF-kB-EGFP activation by HF diet were not uniform but
focal. This suggests that local adherence of bacteria or
production of proinflammatory signaling may contribute to HF
diet induced intestinal inflammation. A small number of
enteroendocrine cells also showed NF-kB
EGFP reporter activa-
tion. This is intriguing because recent studies indicate that
prebiotics, which alter gut microbiota and intestinal permeabil-
ity, can impact on release of gut hormones such as glucagon-like
peptide 2 (GLP-2) [20]. Our findings that HF-diet in conjunction
with the presence of bacteria induces inflammatory signaling in
enteroendocrine cells suggests that modulation of enteroendo-
crine cell function may contribute to the impact of diet:microbial
interactions in mediating obesity.
Figure 8. Immunostaining for antigenic markers (red) and GFP to show absence of co-localization in cells. (A) macrophages; (B)B cells;
(C) neutrophils.
doi:10.1371/journal.pone.0012191.g008
Figure 9. NF-kB
EGFP in intestinal tissue of GF mice treated with HF or LF fecal slurry. Fecal slurry from mice fed HF diet induces NF-kB
EGFP
expression to a greater extent than fecal slurries from mice fed LF diet (Image representative of observation in 3 pairs of mice) in intestine tissues of
GF NF-kB
EGFP mice. Abbreviations: Duo: duodenum; Jej:Jejunum; Ile: ileum; Col:colon.
doi:10.1371/journal.pone.0012191.g009
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correlates with the development of insulin resistance and
obesity
It is well known that overproduction of TNF-a by macrophages
in adipose tissue is an important feature of obesity which is thought
to contribute significantly to the development of insulin resistance
[21,22]. Numerous studies have demonstrated that TNF-a limits
insulin receptor signaling and promotes insulin resistance [15,23].
Additionally, mice with deletion of the TNF-a gene, TNF-a
converting enzyme or receptors for TNF-a are partially resistant to
diet induced obesity and insulin resistance [24,25,26,27]. The
observation here that increases in intestinal TNF-a precede but
strongly correlate with weight gain, body fat, and subsequent
development of insulin resistance, supports a potential role of
intestinal derived TNF-a in the development of DIO and
associated insulin resistance. CONV mice became overtly insulin
resistant as manifest by increased HOMA by 16 weeks after onset
of HF diet. Consistent with prior findings [12,13], GF mice did not
develop insulin resistance as indicated by the lack of significant
difference in HOMA at 16 weeks in GF fed HF=8.562.8 vs GF
fed LF=4.760.7, P.0.05. These values are much lower (P,0.05)
than the HOMA in CONV mice fed HF diet for 16 weeks
(52.2612.7).
TNF-a activates NF-kB and other inflammatory pathways
involved in the etiology of insulin resistance and Type 2 diabetes
[28,29]. Blocking these pathways can alleviate some of the
symptoms of insulin resistance [15,30]. It has been reported that
blocking NF-kB in macrophages or liver attenuated inflammatory
gene expression and insulin resistance on HF diet [31], c-Jun
amino-terminal kinase 1 (JNK1) knockout mice do not become
insulin resistant [32] while blocking JNK improves insulin
sensitivity [33]. These results indicate that these inflammatory
pathways (e.g. IKK, JAK/STAT) may serve as effective targets to
prevent or alleviate the onset of insulin resistance. To date,
adipose-derived macrophages or hepatocytes and hepatic Kupffer
cells have been considered key targets of these beneficial effects of
anti-inflammatory therapy. Our findings that HF diet : bacteria
interactions promote proinflammatory signaling in multiple cell
types in the intestine, although surprisingly not gut macrophages,
suggest that future evaluation of the effects of anti-inflammatory
therapies on HF diet induced gut inflammation and subsequent
weight gain and insulin resistance could be of considerable
interest.
In conclusion, our study demonstrates that HF diet and enteric
bacteria interact to promote inflammatory changes in the intestine,
prior to the development of weight gain, adiposity, and insulin
resistance. The magnitude of induction of the intestinal inflam-
matory biomarker, TNF-a, strongly correlates with HF-diet
induced weight gain, adiposity and insulin resistance in CONV
animals with intact commensal microbiota. These findings suggest
that diet-induced intestinal inflammation may serve as a useful
biomarker for risk assessment of diet-induced obesity and
complications, and that strategies to limit this effect of HF diet
may be beneficial in combating risk of obesity and insulin
resistance.
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